Feledziak_2009_J.Med.Chem_52_7054

Reference

Title : beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase - Feledziak_2009_J.Med.Chem_52_7054
Author(s) : Feledziak M , Michaux C , Urbach A , Labar G , Muccioli GG , Lambert DM , Marchand-Brynaert J
Ref : Journal of Medicinal Chemistry , 52 :7054 , 2009
Abstract :

A library of 30 beta-lactams has been prepared from (3R,4R)-3-[(R)-1'-(tbutyldimethylsilyloxy)-ethyl]-4-acetoxy-2-azetidinone, and the corresponding deacetoxy derivative, by sequential N- and O-functionalizations with various omega-alkenoyl and omega-arylalkanoyl chains. All compounds were selective inhibitors of hFAAH versus hMGL, and IC(50) values in the nanomolar range (5-14 nM) were recorded for the best representatives. From time-dependent preincubation and rapid dilution studies, and from docking analyses in a homology model of the target enzyme, a reversible mechanism of inhibition of hFAAH is proposed.

PubMedSearch : Feledziak_2009_J.Med.Chem_52_7054
PubMedID: 19877691

Related information

Citations formats

Feledziak M, Michaux C, Urbach A, Labar G, Muccioli GG, Lambert DM, Marchand-Brynaert J (2009)
beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase
Journal of Medicinal Chemistry 52 :7054

Feledziak M, Michaux C, Urbach A, Labar G, Muccioli GG, Lambert DM, Marchand-Brynaert J (2009)
Journal of Medicinal Chemistry 52 :7054